Perfil
Carole Monterrat worked as the Chief Financial Officer at Sopartec SA from 2014 to 2018 and as the Vice President-Resources at PROMETHERA Biosciences SA from 2009 to 2014.
She holds a doctorate from Université de Bordeaux and an MBA from Université Catholique de Louvain, which she received in 2008.
Antiguos cargos conocidos de Carole Monterrat.
| Empresas | Cargo | Fin |
|---|---|---|
Sopartec SA
Sopartec SA Investment ManagersFinance Sopartec invests in companies located in Europe. The firm focuses on sectors such as life sciences, AgTech and hard engineering. It participates in seed, early and growth stage capital transactions with an investment size of EUR 0.1 - 7 million. The firm also acts as lead investor. | Director Financiero/CFO | 01/09/2018 |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Corporate Officer/Principal | 01/03/2014 |
Formación de Carole Monterrat.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Sopartec SA
Sopartec SA Investment ManagersFinance Sopartec invests in companies located in Europe. The firm focuses on sectors such as life sciences, AgTech and hard engineering. It participates in seed, early and growth stage capital transactions with an investment size of EUR 0.1 - 7 million. The firm also acts as lead investor. | Finance |
Université de Bordeaux
Université de Bordeaux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
- Bolsa de valores
- Insiders
- Carole Monterrat
















